Respiratory Syncytial Virus - RSV Protocol

clinical trial

MedicalStudy clinical_trial Q61957531

Press Enter · cited answer in seconds

Summary

Respiratory Syncytial Virus - RSV Protocol is a clinical trial^[1].

Key Facts

Respiratory Syncytial Virus - RSV Protocol is in the country of United States^[2].
Respiratory Syncytial Virus - RSV Protocol's instance of is recorded as clinical trial^[3].
Respiratory Syncytial Virus - RSV Protocol's start time is recorded as +2011-12-31T00:00:00Z^[4].
Respiratory Syncytial Virus - RSV Protocol's end time is recorded as +2019-12-31T00:00:00Z^[5].
Respiratory Syncytial Virus - RSV Protocol's sponsor is recorded as The University of Texas MD Anderson Cancer Center^[6].
Respiratory Syncytial Virus - RSV Protocol's main subject is recorded as respiratory syncytial virus infectious disease^[7].
Respiratory Syncytial Virus - RSV Protocol's main subject is recorded as pneumonia^[8].
Respiratory Syncytial Virus - RSV Protocol's number of participants is recorded as {'unit': '1', 'amount': '+96'}^[9].
Respiratory Syncytial Virus - RSV Protocol's title is recorded as An Open Label Randomized Controlled Trial To Prevent the Progression of Respiratory Syncytial Virus Upper Respiratory Tract Infection to Lower Respiratory Tract Infection in Patients After Hematopoietic Stem Cell Transplant^[10].
Respiratory Syncytial Virus - RSV Protocol's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}^[11].
Respiratory Syncytial Virus - RSV Protocol's ClinicalTrials.gov ID is recorded as NCT01502072^[12].
Respiratory Syncytial Virus - RSV Protocol's research intervention is recorded as ribavirin^[13].
Respiratory Syncytial Virus - RSV Protocol's clinical trial phase is recorded as phase II clinical trial^[14].
Respiratory Syncytial Virus - RSV Protocol's research site is recorded as The University of Texas MD Anderson Cancer Center^[15].
Respiratory Syncytial Virus - RSV Protocol's research subject recruitment status is recorded as completed^[16].
Respiratory Syncytial Virus - RSV Protocol's study type is recorded as interventional study^[17].

⭐ Popularity Graph

0/100 long tail

⛏️ Lake Facts · open-dataset statements via 4ort-mint

From open datasets, joined by identifier and shown only for properties Wikidata does not state on this entity — except where the dataset is the registry authority for the fact (ClinicalTrials.gov on trial registration data): there its value is shown instead, with Wikidata's noted beside it. Every row carries its dataset edition and licence.

Number of participantsP1132

48 (ACTUAL) 2026-09-26 Wikidata lists 96 ClinicalTrials.gov (US Government Public Domain)

Start timeP580

2011-12-28 2026-09-26 Wikidata lists 2011-12-31 ClinicalTrials.gov (US Government Public Domain)

End timeP582

2020-02-01 2026-09-26 Wikidata lists 2019-12-31 ClinicalTrials.gov (US Government Public Domain)

Medical conditionP1050

respiratory syncytial virus infectious disease 2026-09-26 ClinicalTrials.gov (US Government Public Domain)

ClinicalTrials.gov (data processed by ClinicalTrials.gov on 2026-09-26); U.S. federal government data, public domain; lake licence_code custom-review

Quick Facts

Instance of clinical trial

Country United States

Properties

Clinical trial phase phase II clinical trial

End time December 31, 2019

Imported from wholeness_audit_2026-05-02

Main subject respiratory syncytial virus infectious disease, pneumonia

Minimum age 18 year

Number of participants 96

Research intervention ribavirin

Research site The University of Texas MD Anderson Cancer Center

Research subject recruitment status completed

Sponsor The University of Texas MD Anderson Cancer Center

Start time December 31, 2011

Study type interventional study

Title An Open Label Randomized Controlled Trial To Prevent the Progression of Respiratory Syncytial Virus Upper Respiratory Tract Infection to Lower Respiratory Tract Infection in Patients After Hematopoietic Stem Cell Transplant

External References (1)

Clinicaltrials.gov id NCT01502072

🏷️ Also known as

en Respiratory Syncytial Virus - RSV Protocol

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

Class ancestry

[1] ↑ Respiratory Syncytial Virus - RSV Protocol is an instance of clinical trial (Q30612) [P31, primary]. Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA

4ort.xyz Knowledge Graph. (2026). Respiratory Syncytial Virus - RSV Protocol. Retrieved May 3, 2026, from https://4ort.xyz/entity/respiratory-syncytial-virus-rsv-protocol

MLA

“Respiratory Syncytial Virus - RSV Protocol.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/respiratory-syncytial-virus-rsv-protocol.

BibTeX

@misc{4ortxyz_respiratory-syncytial-virus-rsv-protocol_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Respiratory Syncytial Virus - RSV Protocol}}, year = {2026}, url = {https://4ort.xyz/entity/respiratory-syncytial-virus-rsv-protocol}, note = {Accessed: 2026-05-03}}

LLM prompt

According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Respiratory Syncytial Virus - RSV Protocol — https://4ort.xyz/entity/respiratory-syncytial-virus-rsv-protocol (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/respiratory-syncytial-virus-rsv-protocol · Last refreshed: May 3, 2026